# Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets

> **NCT06606860** · PHASE1 · COMPLETED · sponsor: **Swiss Tropical & Public Health Institute** · enrollment: 45 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oxantel Pamoate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06606860
- **Lead sponsor:** Swiss Tropical & Public Health Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-27
- **Primary completion:** 2025-04-08
- **Final completion:** 2025-04-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06606860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06606860, "Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06606860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*